Close Menu


Entry Denied

Politico reports that a Food and Drug Administration official was not allowed to enter a Centers for Disease Control and Prevention campus, possibly due to a scheduling mix-up.

The agency issued guidance noting that labs can test only the most challenging sample type and can use inactivated virus spiked into negative samples. 

The company said its Liberty16 device is capable of detecting viral infection quickly, and can be deployed where other PCR instruments are too big to go.

According to a US Food and Drug Administration webinar yesterday, a lot of IDT test kits has been qualified by CDC and is authorized for purchase.

Pursuant to expanded guidelines announced over the weekend, New York State public health labs have been granted emergency authorization.

The agency issued guidance, effective immediately, that describe the circumstances in which it will allow labs to perform such testing.

Labs can deploy the test kit omitting the pan-SARS component, and new kits that are specific only to SARS-CoV-2 are being manufactured. 

Add the Missing Data

A federal judge has ruled that drug companies, device manufacturers, and universities need to provide missing clinical data from hundreds of trials to a federal website, ScienceInsider reports.

Test volumes, revenues per test and costs per test improved during the quarter, the company said.

Walking Around

A Minnesota toddler given a gene therapy to treat her spinal muscular atrophy is now walking, according to Newsweek.


Master's and doctoral students in the UK call on funding groups to extend their grants for the duration of the disruption caused by the COVID-19 outbreak, the Guardian reports.

Squid can make edits to their RNA within the cytoplasm of their axons, Science News reports.

The Chan Zuckerberg Initiative is putting $25 million toward COVID-19 treatment research, according to the Verge.

In Science this week: researchers engineer version of Cas9 that is nearly PAM-less, and more.